Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001085037-07-002181
Filing Date
2007-09-26
Accepted
2007-09-25 18:51:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A AMENDMENT NO. 1 sched13dsep07.htm SC 13D/A 93717
  Complete submission text file 0001085037-07-002181.txt   95531
Mailing Address 101-4837 CANYON RIDGE CRESENT KELOWNA A1 V1W 4A1
Business Address 101-4837 CANYON RIDGE CRESENT KELOWNA A1 V1W 4A1 250-764-9701
ANAVEX LIFE SCIENCES CORP. (Subject) CIK: 0001314052 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-81767 | Film No.: 071135243
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 14,RUE KLEBERG GENEVA V8 CH-1201
Business Address 30 6937 060794
Skarpelos Athanasios (Filed by) CIK: 0001360570 (see all company filings)

Type: SC 13D/A